Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
European Archives of Psychiatry and Clinical Neuroscience|June 20, 2006
The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressantsNorbert Thuerauf, Jens LunkenheimerEuropean Archives of Psychiatry and Clinical Neuroscience|June 20, 2006
The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseasesNorbert Thuerauf, Martin Friedrich FrommNeuroscience Letters|February 7, 2012
Olfactory abnormalities in anxiety disordersMarion Clepce, Karin Reich, Andrea Gossler, et al.Psychiatry Research|October 24, 2012
Olfactory perception in schizophrenia: the rating range for hedonic judgements is increased during acute episodesMarion Clepce, Karin Reich, Andrea Gossler, et al.Neuroscience Letters|January 26, 2010
The relation between depression, anhedonia and olfactory hedonic estimates--a pilot study in major depressionMarion Clepce, Andrea Gossler, Karin Reich, et al.Clinical Pharmacology and Therapeutics|April 30, 2004
CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot studyThomas Rau, Gerlinde Wohlleben, Henrike Wuttke, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
The influence of mecamylamine on trigeminal and olfactory chemoreception of nicotineNorbert Thuerauf, Katrin Markovic, Georg Braun, et al.Chemical Senses|September 30, 2016
Development and Validation of a Food-Associated Olfactory Test (FAOT)Melanie Yvonne Denzer-Lippmann, Jonathan Beauchamp, Jessica Freiherr, et al.Case Reports in Psychiatry|January 14, 2014
Catatonic dilemma in a 33-year-old woman: a discussionAlexander Koch, Karin Reich, Jan Wielopolski, et al.Critical Care (London, England)|January 16, 2007
Managing an effective treatment for neuroleptic malignant syndromeUdo Reulbach, Carmen Dütsch, Teresa Biermann, et al.Pageof 3